<DOC>
	<DOCNO>NCT00002934</DOCNO>
	<brief_summary>RATIONALE : The evaluation breast cancer recurrence rate may improve ability plan cancer treatment patient breast cancer . PURPOSE : Study evaluate rate recurrence breast cancer woman surgery ductal carcinoma situ .</brief_summary>
	<brief_title>Evaluation Breast Cancer Recurrence Rates Following Surgery Women With Ductal Carcinoma In Situ</brief_title>
	<detailed_description>OBJECTIVES : - Evaluate actuarial local situ invasive recurrence rate 5 10 year local excision woman favorable ductal carcinoma situ ( DCIS ) prognosis . - Evaluate concordance institutional pathologist central review pathologist respect diagnosis grading DCIS . - Identify parameter indicate increase decreased risk recurrence absence irradiation . - Evaluate pattern salvage recurrence rate breast conservation . - Evaluate actuarial relapse-free , overall , cause-specific survival 5 10 year post DCIS excision . OUTLINE : This registration study stratify histologic grade ( high v low intermediate ) adjuvant tamoxifen therapy ( yes v ) . Patients receive standard clinical mammographic follow-up great 10 year . If recurrence occur , treatment discretion investigator . Patients may receive adjuvant oral tamoxifen daily 5 year local excision . A follow magnification view mammogram must take last local excision , microcalcification must negative . Patients follow every 6 month first 10 year , annually thereafter . PROJECTED ACCRUAL : 1000 ( 500 per stratum ) eligible evaluable patient enrol estimate accrual rate 250 patient per year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven low intermediate grade ductal carcinoma situ ( DCIS ) breast No great 2.5 cm great dimension OR Histologically proven highgrade DCIS breast No great 1 cm great dimension Region DCIS must least 2.5 mm great dimension ( mammographic estimate size allow pathologic measurement impossible ) DCIS must nonpalpable ; detect mammogram find incidentally breast biopsy Pathologically confirm negative margin least 3 mm Breast must suitable breast conserve therapy Proper tumor size versus breast size No carcinoma suspicious mammogram finding breast sit No prior situ invasive breast cancer Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 18 Sex : Female Menopausal status : Not specify Performance status : Not specify Life expectancy : Greater 5 year Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Cardiovascular : Not specify Other : No invasive malignancy within past 10 year except nonmelanomatous skin cancer carcinoma situ cervix No known HIV infection No Paget 's nipple disease PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Adjuvant tamoxifen allow Radiotherapy : No prior radiotherapy breast No adjuvant radiotherapy Surgery : Not specify</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>breast cancer situ</keyword>
	<keyword>ductal breast carcinoma</keyword>
</DOC>